Phase I Trial of Dabrafenib and Pazopanib in BRAF Mutated Advanced Malignancies.
Haraldsdottir S, Janku F, Poi M, Timmers C, Geyer S, Schaaf LJ, Sexton J, Wei L, Thurmond J, Velez-Bravo V, Stepanek VM, Bertino EM, Kendra K, Mortazavi A, Subbiah V, Phelps M, Shah MH.
Haraldsdottir S, et al.
JCO Precis Oncol. 2018 Nov;2:1-19. doi: 10.1200/PO.17.00247.
JCO Precis Oncol. 2018.
PMID: 35135123